Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Scilex Holding Co has 17 disclosed suppliers and 5 disclosed customers. Each one is named in an SEC filing, either Scilex Holding Co’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In the years ended December 31, 2020, and 2021, and in the first quarter of 2022, Cardinal Health 105 was our only customer and sales to Cardinal Health 105 represented all of our net revenue for such periods.”
$30M relationship
basisSCLX fy2025 · closed 2025-12 $30M
FILING10-K0001193125-26-151455cik 0001820190
“Prior to April 2022, we relied on a single third-party logistics distribution provider, Cardinal Health 105, for ZTlido distribution in the United States.”
FILING10-K0001193125-26-151455cik 0001820190
“In February 2013, Scilex Pharma became a party to a product development agreement (as amended, the "Product Development Agreement") with Itochu and Oishi (together, the "Developers"), pursuant to which the Developers will manufacture and supply lidocaine tape products, including ZTlido and SP-103, for Scilex Pharma.”
FILING10-K0001193125-26-151455cik 0001820190
“In February 2013, Scilex Pharma became a party to a product development agreement (as amended, the "Product Development Agreement") with Itochu and Oishi (together, the "Developers"), pursuant to which the Developers will manufacture and supply lidocaine tape products, including ZTlido and SP-103, for Scilex Pharma.”
FILING10-K0001193125-26-151455cik 0001820190
“Historically, we have purchased our clinical and commercial supply requirements for sodium hyaluronate, one of the excipients for SP-102, from Genzyme pursuant to a supply agreement, which terminated as of May 31, 2024.”
FILING10-K0001193125-26-151455cik 0001820190
“Itochu agreed to purchase Products from Oishi and handle the shipping of the Products.”
FILING10-K0001193125-26-151455cik 0001820190
“Pursuant to the Lifecore Master Services Agreement, Lifecore is responsible for clinical trial material manufacturing and development services for SEMDEXA as set forth in each separate statement of work (each a "Lifecore Statement of Work").”
FILING10-K0001193125-26-151455cik 0001820190
“In April 2025, Scilex Bio, Inc. ("Scilex Bio"), our subsidiary, signed an agreement with NeuroBiogen Company ("NBG") to grant Scilex Bio an exclusive worldwide license to the franchise KDS2010 drug candidate to develop and commercialize in metabolic diseases (including obesity and type 2 diabetes) and neurodegenerative diseases, including Alzheimer's, Parkinson's and other CNS diseases.”
FILING10-K0001193125-26-151455cik 0001820190
“In June 2022, we entered into the Romeg License Agreement with Romeg, which agreement was subsequently amended in January 2025, to acquire certain rights to GLOPERBA and the exclusive license to use the trademark "GLOPERBA®".”
FILING10-K0001193125-26-151455cik 0001820190
“We acquired certain rights to GLOPERBA and the exclusive license to use the trademark "GLOPERBA®", pursuant to a License and Commercialization Agreement we entered into with RxOmeg Therapeutics LLC (a/k/a Romeg Therapeutics, LLC) ("Romeg"), dated as of June 14, 2022, which agreement was subsequently amended on January 16, 2025 (such agreement, as so amended, the "Romeg License Agreement").”
FILING10-K0001193125-26-151455cik 0001820190
“We acquired SP-102 from Semnur Pharmaceuticals, Inc. ("Semnur") in March 2019 and are developing SP-102 to be an injectable viscous gel formulation of a widely used corticosteroid designed to address the serious risks posed by off-label epidural steroid injections ("ESI"), which are administered over 12 million times annually in the United States.”
FILING10-K0001193125-26-151455cik 0001820190
“Subsequent to the acquisition, Sorrento designated Legacy Scilex to lead all development efforts related to SP-104 and on May 12, 2022, Legacy Scilex and Sorrento entered into a bill of sale and assignment and assumption agreement (the "Bill of Sale"), pursuant to which Sorrento sold, conveyed, assigned and transferred to Legacy Scilex all of its rights, title and interest in and to the SP-104 Assets (including PCT/US2021/053645 and all patents and patent applications that claim priority rights thereto) and Legacy Scilex assumed all of Sorrento's rights, liabilities and obligations under the Aardvark Asset Purchase Agreement (the "SP-104 Acquisition").”
FILING10-K0001193125-26-151455cik 0001820190
“On May 12, 2025, Scilex signed an agreement with Syneos Health Commercial Services, LLC to provide sales force outsourcing activities which the outsourced sales force would continue to dedicate all of their efforts to Scilex products.”
FILING10-K0001193125-26-151455cik 0001820190
“We currently contract with multiple pharmaceutical distributors throughout the United States, including McKesson Corporation ("McKesson"), Cardinal Health 110, LLC ("Cardinal Health 110") and AmerisourceBergen Corporation ("AmerisourceBergen").”
FILING10-K0001193125-26-151455cik 0001820190
“We currently contract with multiple pharmaceutical distributors throughout the United States, including McKesson Corporation ("McKesson"), Cardinal Health 110, LLC ("Cardinal Health 110") and AmerisourceBergen Corporation ("AmerisourceBergen").”
FILING10-K0001193125-26-151455cik 0001820190
“We currently contract with multiple pharmaceutical distributors throughout the United States, including McKesson Corporation ("McKesson"), Cardinal Health 110, LLC ("Cardinal Health 110") and AmerisourceBergen Corporation ("AmerisourceBergen").”
FILING10-K0001193125-26-151455cik 0001820190
“StockBlock and its affiliate, Rodman & Renshaw LLC acted as exclusive placement agents (the "Placement Agents") in connection with the April 2024 RDO.”
FILING10-K0001193125-26-151455cik 0001820190
“StockBlock and its affiliate, Rodman & Renshaw LLC acted as exclusive placement agents (the "Placement Agents") in connection with the April 2024 RDO.”
FILING10-K0001193125-26-151455cik 0001820190
“In November 2024, we delivered the Additional Product to Endeavor and fully satisfied the remaining obligations in respect of the FSF Deposit.”
FILING10-K0001193125-26-151455cik 0001820190
“On December 22, 2023, we entered into a Sales Agreement (the "ATM Sales Agreement") with B. Riley Securities, Inc., Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (the "Sales Agents"), which agreement was voluntarily terminated by us effective as of March 5, 2025.”
FILING10-K0001193125-26-151455cik 0001820190
“On December 22, 2023, we entered into a Sales Agreement (the "ATM Sales Agreement") with B. Riley Securities, Inc., Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (the "Sales Agents"), which agreement was voluntarily terminated by us effective as of March 5, 2025.”
FILING10-K0001193125-26-151455cik 0001820190
“On December 22, 2023, we entered into a Sales Agreement (the "ATM Sales Agreement") with B. Riley Securities, Inc., Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (the "Sales Agents"), which agreement was voluntarily terminated by us effective as of March 5, 2025.”
FILING10-K0001193125-26-151455cik 0001820190
Watchlist prices, news filtered to it, and its next report on your desk.
Prev close 4.93 · gapped above the open, then crossed back over prior close. High/low 5.25 at 4:15 pm ET, 4.92 at 3:30 pm ET.
Scilex Holding Co
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
SCLX (Scilex Holding Co) has 17 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.